Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 416

1.

The 5th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 30th to December 2nd, 2017.

Tominaga E, Kobayashi Y, Aoki D.

J Gynecol Oncol. 2018 Mar;29(2):e33. doi: 10.3802/jgo.2018.29.e33. No abstract available.

PMID:
29468857
2.

Dimensionality Driven Enhancement of Ferromagnetic Superconductivity in URhGe.

Braithwaite D, Aoki D, Brison JP, Flouquet J, Knebel G, Nakamura A, Pourret A.

Phys Rev Lett. 2018 Jan 19;120(3):037001. doi: 10.1103/PhysRevLett.120.037001.

PMID:
29400517
3.

Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer.

Takeda T, Tsuji K, Banno K, Yanokura M, Kobayashi Y, Tominaga E, Aoki D.

J Gynecol Oncol. 2018 Jan 30. doi: 10.3802/jgo.2018.29.e29. [Epub ahead of print]

4.

Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer.

Mikami M, Shida M, Shibata T, Katabuchi H, Kigawa J, Aoki D, Yaegashi N.

J Gynecol Oncol. 2018 Mar;29(2):e23. doi: 10.3802/jgo.2018.29.e23. Epub 2017 Dec 27.

5.

Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?

Yamagami W, Susumu N, Makabe T, Sakai K, Nomura H, Kataoka F, Hirasawa A, Banno K, Aoki D.

J Gynecol Oncol. 2018 Mar;29(2):e21. doi: 10.3802/jgo.2018.29.e21. Epub 2018 Jan 2.

6.

Radiation-induced angiosarcoma of the omentum diagnosed by laparoscopy: A case report.

Kunitomi H, Banno K, Iseki H, Sera A, Miyauchi A, Kobayashi Y, Hayashi S, Tominaga E, Sasaki A, Kawaida M, Kameyama K, Aoki D.

Mol Clin Oncol. 2018 Feb;8(2):264-268. doi: 10.3892/mco.2017.1513. Epub 2017 Nov 27.

7.

Erratum: Recent advances in the molecular mechanisms of Mayer-Rokitansky-Küster-Hauser syndrome.

Watanabe K, Kobayashi Y, Banno K, Matoba Y, Kunitomi H, Nakamura K, Adachi M, Umene K, Kisu I, Tominaga E, Aoki D.

Biomed Rep. 2018 Jan;8(1):106. doi: 10.3892/br.2017.1018. Epub 2017 Nov 13.

8.

Which one is Bulkier: the 3,5-Dimethylphenyl or the 2,6-Dimethylphenyl Group? Development of Size-Complementary Molecular and Macromolecular [2]Rotaxanes.

Sato H, Aoki D, Takata T.

Chem Asian J. 2018 Feb 2. doi: 10.1002/asia.201800170. [Epub ahead of print]

PMID:
29392843
9.

Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer.

Hirasawa A, Imoto I, Naruto T, Akahane T, Yamagami W, Nomura H, Masuda K, Susumu N, Tsuda H, Aoki D.

Oncotarget. 2017 Nov 28;8(68):112258-112267. doi: 10.18632/oncotarget.22733. eCollection 2017 Dec 22.

10.

Mechanochromic Polymers That Turn Green Upon the Dissociation of Diarylbibenzothiophenonyl: The Missing Piece toward Rainbow Mechanochromism.

Ishizuki K, Oka H, Aoki D, Goseki R, Otsuka H.

Chemistry. 2018 Jan 16. doi: 10.1002/chem.201800194. [Epub ahead of print]

PMID:
29338101
11.

Multicenter Clinicopathological Study of High-Grade Serous Carcinoma Presenting as Primary Peritoneal Carcinoma.

Komiyama S, Nishijima Y, Kondo H, Nomura H, Yamaguchi S, Futagami M, Arai H, Yokoyama Y, Suzuki N, Mikami M, Kubushiro K, Aoki D, Udagawa Y, Nishimura R.

Int J Gynecol Cancer. 2018 Jan 12. doi: 10.1097/IGC.0000000000001167. [Epub ahead of print]

PMID:
29324533
12.

ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell death.

Ueno M, Shiomi T, Mochizuki S, Chijiiwa M, Shimoda M, Kanai Y, Kataoka F, Hirasawa A, Susumu N, Aoki D, Okada Y.

Cancer Sci. 2018 Feb;109(2):471-482. doi: 10.1111/cas.13469.

13.

Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference.

Bookman MA, Okamoto A, Stuart G, Yanaihara N, Aoki D, Bacon M, Fujiwara K, González-Martín A, Harter P, Kim JW, Ledermann J, Pujade-Lauraine E, Quinn M, Ochiai K; 5th Ovarian Cancer Consensus Conference.

Ann Oncol. 2017 Nov 1;28(suppl_8):viii30-viii35. doi: 10.1093/annonc/mdx449.

PMID:
29232472
14.

Re: Starting a uterus transplantation service: notes from a small island.

Kisu I, Matoba Y, Banno K, Aoki D.

BJOG. 2018 Mar;125(4):515-516. doi: 10.1111/1471-0528.15018. Epub 2017 Dec 6. No abstract available.

PMID:
29210187
15.

Recent findings on epigenetic gene abnormalities involved in uterine cancer.

Yanokura M, Banno K, Kobayashi Y, Nomura H, Hayashi S, Tominaga E, Aoki D.

Mol Clin Oncol. 2017 Nov;7(5):733-737. doi: 10.3892/mco.2017.1428. Epub 2017 Sep 20.

16.

Aberrant chromatin remodeling in gynecological cancer.

Okawa R, Banno K, Iida M, Yanokura M, Takeda T, Iijima M, Kunitomi-Irie H, Nakamura K, Adachi M, Umene K, Nogami Y, Masuda K, Kobayashi Y, Tominaga E, Aoki D.

Oncol Lett. 2017 Nov;14(5):5107-5113. doi: 10.3892/ol.2017.6891. Epub 2017 Sep 6.

17.

SIM2l attenuates resistance to hypoxia and tumor growth by transcriptional suppression of HIF1A in uterine cervical squamous cell carcinoma.

Nakamura K, Komatsu M, Chiwaki F, Takeda T, Kobayashi Y, Banno K, Aoki D, Yoshida T, Sasaki H.

Sci Rep. 2017 Nov 6;7(1):14574. doi: 10.1038/s41598-017-15261-4.

18.

Allowable warm ischemic time and morphological and biochemical changes in uterine ischemia/reperfusion injury in cynomolgus macaque: a basic study for uterus transplantation.

Kisu I, Umene K, Adachi M, Emoto K, Nogami Y, Banno K, Itagaki I, Kawamoto I, Nakagawa T, Narita H, Yoshida A, Tsuchiya H, Ogasawara K, Aoki D.

Hum Reprod. 2017 Dec 1;32(12):2581. doi: 10.1093/humrep/dex325. No abstract available.

PMID:
29077872
19.

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer.

Kobayashi Y, Kashima H, Rahmanto YS, Banno K, Yu Y, Matoba Y, Watanabe K, Iijima M, Takeda T, Kunitomi H, Iida M, Adachi M, Nakamura K, Tsuji K, Masuda K, Nomura H, Tominaga E, Aoki D.

Oncotarget. 2017 Aug 7;8(42):72147-72156. doi: 10.18632/oncotarget.20046. eCollection 2017 Sep 22.

20.

Echinochloa crus-galli genome analysis provides insight into its adaptation and invasiveness as a weed.

Guo L, Qiu J, Ye C, Jin G, Mao L, Zhang H, Yang X, Peng Q, Wang Y, Jia L, Lin Z, Li G, Fu F, Liu C, Chen L, Shen E, Wang W, Chu Q, Wu D, Wu S, Xia C, Zhang Y, Zhou X, Wang L, Wu L, Song W, Wang Y, Shu Q, Aoki D, Yumoto E, Yokota T, Miyamoto K, Okada K, Kim DS, Cai D, Zhang C, Lou Y, Qian Q, Yamaguchi H, Yamane H, Kong CH, Timko MP, Bai L, Fan L.

Nat Commun. 2017 Oct 18;8(1):1031. doi: 10.1038/s41467-017-01067-5.

21.

Decoupled Thermo- and pH-Responsive Hydrogel Microspheres Cross-Linked by Rotaxane Networks.

Kureha T, Aoki D, Hiroshige S, Iijima K, Aoki D, Takata T, Suzuki D.

Angew Chem Int Ed Engl. 2017 Nov 27;56(48):15393-15396. doi: 10.1002/anie.201709633. Epub 2017 Oct 26.

PMID:
28994501
22.

Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3).

Watari H, Katayama H, Shibata T, Ushijima K, Satoh T, Onda T, Aoki D, Fukuda H, Yaegashi N, Sakuragi N; Gynecologic Cancer Study Group of the Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2017 Oct 1;47(10):986-990. doi: 10.1093/jjco/hyx108.

PMID:
28981739
23.

Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer.

Yoshihama T, Nomura H, Iwasa N, Kataoka F, Hashimoto S, Nanki Y, Hirano T, Makabe T, Sakai K, Yamagami W, Hirasawa A, Aoki D.

Jpn J Clin Oncol. 2017 Nov 1;47(11):1019-1023. doi: 10.1093/jjco/hyx118.

PMID:
28973541
24.

Allowable warm ischemic time and morphological and biochemical changes in uterine ischemia/reperfusion injury in cynomolgus macaque: a basic study for uterus transplantation.

Kisu I, Umene K, Adachi M, Emoto K, Nogami Y, Banno K, Itagaki I, Kawamoto I, Nakagawa T, Narita H, Yoshida A, Tsuchiya H, Ogasawara K, Aoki D.

Hum Reprod. 2017 Oct 1;32(10):2026-2035. doi: 10.1093/humrep/dex250.

PMID:
28938750
25.

New use of microsatellite instability analysis in endometrial cancer.

Kunitomi H, Banno K, Yanokura M, Takeda T, Iijima M, Nakamura K, Iida M, Adachi M, Watanabe K, Matoba Y, Kobayashi Y, Tominaga E, Aoki D.

Oncol Lett. 2017 Sep;14(3):3297-3301. doi: 10.3892/ol.2017.6640. Epub 2017 Jul 20.

26.

Phase II basket trial of perifosine monotherapy for recurrent gynecologic cancer with or without PIK3CA mutations.

Hasegawa K, Kagabu M, Mizuno M, Oda K, Aoki D, Mabuchi S, Kamiura S, Yamaguchi S, Aoki Y, Saito T, Yunokawa M, Takehara K, Okamoto A, Ochiai K, Kimura T.

Invest New Drugs. 2017 Dec;35(6):800-812. doi: 10.1007/s10637-017-0504-6. Epub 2017 Sep 2.

PMID:
28864978
27.

Final report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology, on a fact-finding questionnaire on the status of treatment of hereditary breast and ovarian cancer syndrome in Japan.

Satoh T, Takamatsu K, Takeshima N, Kobayashi H, Aoki D, Suzuki N.

J Obstet Gynaecol Res. 2017 Sep;43(9):1377-1380. doi: 10.1111/jog.13409. Epub 2017 Aug 17.

PMID:
28833906
28.

CITRUS, cervical cancer screening trial by randomization of HPV testing intervention for upcoming screening: Design, methods and baseline data of 18,471 women.

Morisada T, Teramoto K, Takano H, Sakamoto I, Nishio H, Iwata T, Hashi A, Katoh R, Okamoto A, Sasaki H, Nakatani E, Teramukai S, Aoki D.

Cancer Epidemiol. 2017 Oct;50(Pt A):60-67. doi: 10.1016/j.canep.2017.07.017. Epub 2017 Aug 16.

PMID:
28818742
29.

Recent advances in the molecular mechanisms of Mayer-Rokitansky-Küster-Hauser syndrome.

Watanabe K, Kobayashi Y, Banno K, Matoba Y, Kunitomi H, Nakamura K, Adachi M, Umene K, Kisu I, Tominaga E, Aoki D.

Biomed Rep. 2017 Aug;7(2):123-127. doi: 10.3892/br.2017.929. Epub 2017 Jun 21. Erratum in: Biomed Rep. 2018 Jan;8(1):106.

30.

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma.

Itamochi H, Oishi T, Oumi N, Takeuchi S, Yoshihara K, Mikami M, Yaegashi N, Terao Y, Takehara K, Ushijima K, Watari H, Aoki D, Kimura T, Nakamura T, Yokoyama Y, Kigawa J, Sugiyama T.

Br J Cancer. 2017 Aug 22;117(5):717-724. doi: 10.1038/bjc.2017.228. Epub 2017 Jul 20.

PMID:
28728166
31.

Distribution of salicifoline in freeze-fixed stems of Magnolia kobus as observed by cryo-TOF-SIMS.

Okumura W, Aoki D, Matsushita Y, Yoshida M, Fukushima K.

Sci Rep. 2017 Jul 19;7(1):5939. doi: 10.1038/s41598-017-06444-0.

32.

Comparison Between Laparoscopy and Laparotomy in Systematic Para-Aortic Lymphadenectomy for Patients with Endometrial Cancer: A Retrospective Multicenter Study.

Tanaka T, Terai Y, Hayashi S, Aoki D, Miki M, Kobayashi E, Kimura T, Baba T, Matsumura N, Ohmichi M.

J Gynecol Surg. 2017 Jun 1;33(3):105-110. doi: 10.1089/gyn.2016.0101.

33.

A Comparison of Dye Versus Fluorescence Methods for Sentinel Lymph Node Mapping in Endometrial Cancer.

Yamagami W, Susumu N, Kataoka F, Makabe T, Sakai K, Ninomiya T, Wada M, Nomura H, Hirasawa A, Banno K, Nakahara T, Kameyama K, Aoki D.

Int J Gynecol Cancer. 2017 Sep;27(7):1517-1524. doi: 10.1097/IGC.0000000000000997.

PMID:
28562470
34.

Field-induced magnetic instability within a superconducting condensate.

Mazzone DG, Raymond S, Gavilano JL, Ressouche E, Niedermayer C, Birk JO, Ouladdiaf B, Bastien G, Knebel G, Aoki D, Lapertot G, Kenzelmann M.

Sci Adv. 2017 May 19;3(5):e1602055. doi: 10.1126/sciadv.1602055. eCollection 2017 May.

35.

Formation of Tough Films by Evaporation of Water from Dispersions of Elastomer Microspheres Crosslinked with Rotaxane Supramolecules.

Hiroshige S, Kureha T, Aoki D, Sawada J, Aoki D, Takata T, Suzuki D.

Chemistry. 2017 Jun 22;23(35):8405-8408. doi: 10.1002/chem.201702077. Epub 2017 Jun 5.

PMID:
28493449
36.

Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer.

Iijima M, Banno K, Okawa R, Yanokura M, Iida M, Takeda T, Kunitomi-Irie H, Adachi M, Nakamura K, Umene K, Nogami Y, Masuda K, Tominaga E, Aoki D.

Oncol Lett. 2017 Mar;13(3):1063-1070. doi: 10.3892/ol.2017.5582. Epub 2017 Jan 10.

37.

Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.

Yanokura M, Banno K, Adachi M, Aoki D, Abe K.

Int J Oncol. 2017 Jun;50(6):1934-1946. doi: 10.3892/ijo.2017.3966. Epub 2017 Apr 19.

38.

Mid-trimester residual cervical length and the risk of preterm birth in pregnancies after abdominal radical trachelectomy: a retrospective analysis.

Kasuga Y, Miyakoshi K, Nishio H, Akiba Y, Otani T, Fukutake M, Ikenoue S, Ochiai D, Matsumoto T, Tanaka K, Minegishi K, Kuji N, Roberts R, Aoki D, Tanaka M.

BJOG. 2017 Oct;124(11):1729-1735. doi: 10.1111/1471-0528.14688. Epub 2017 May 22.

PMID:
28418597
39.

A Rational Entry to Cyclic Polymers via Selective Cyclization by Self-Assembly and Topology Transformation of Linear Polymers.

Aoki D, Aibara G, Uchida S, Takata T.

J Am Chem Soc. 2017 May 24;139(20):6791-6794. doi: 10.1021/jacs.7b01151. Epub 2017 Apr 26.

PMID:
28388036
40.

Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.

Nanki Y, Chiyoda T, Kataoka F, Nomura H, Nakadaira N, Iwasa N, Hashimoto S, Arima H, Susumu N, Aoki D.

J Obstet Gynaecol Res. 2017 Apr;43(4):744-748. doi: 10.1111/jog.13271. Epub 2017 Mar 28.

PMID:
28370831
41.

Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.

Masuda K, Hirasawa A, Irie-Kunitomi H, Akahane T, Ueki A, Kobayashi Y, Yamagami W, Nomura H, Kataoka F, Tominaga E, Banno K, Susumu N, Aoki D.

Jpn J Clin Oncol. 2017 May 1;47(5):473. doi: 10.1093/jjco/hyx037. No abstract available.

42.

Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.

Masuda K, Hirasawa A, Irie-Kunitomi H, Akahane T, Ueki A, Kobayashi Y, Yamagami W, Nomura H, Kataoka F, Tominaga E, Banno K, Susumu N, Aoki D.

Jpn J Clin Oncol. 2017 May 1;47(5):401-406. doi: 10.1093/jjco/hyx019. Erratum in: Jpn J Clin Oncol. 2017 May 1;47(5):473.

43.

Pairing mechanism in the ferromagnetic superconductor UCoGe.

Wu B, Bastien G, Taupin M, Paulsen C, Howald L, Aoki D, Brison JP.

Nat Commun. 2017 Feb 23;8:14480. doi: 10.1038/ncomms14480.

44.

Clinical statistics of gynecologic cancers in Japan.

Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Aoki D, Katabuchi H.

J Gynecol Oncol. 2017 Mar;28(2):e32. doi: 10.3802/jgo.2017.28.e32. Epub 2017 Feb 10. Review.

45.

UGT1A1 polymorphism as a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecan.

Yoshihama T, Hirasawa A, Nomura H, Akahane T, Nanki Y, Yamagami W, Kataoka F, Tominaga E, Susumu N, Mushiroda T, Aoki D.

Jpn J Clin Oncol. 2017 Feb 4;47(2):170-174. doi: 10.1093/jjco/hyw163.

PMID:
28173214
46.

Translocation of 133Cs administered to Cryptomeria japonica wood.

Aoki D, Asai R, Tomioka R, Matsushita Y, Asakura H, Tabuchi M, Fukushima K.

Sci Total Environ. 2017 Apr 15;584-585:88-95. doi: 10.1016/j.scitotenv.2017.01.159. Epub 2017 Jan 28.

PMID:
28135617
47.

Effective Selection of a Well-Differentiated Type of Human Uterine Endometrial Carcinoma Cells by Transfection of the Sulfotransferase Gene and Possible Association of Sulfoglycolipids With Well-Differentiated Phenotypes.

Tanaka K, Ishiwata I, Kubushiro K, Mikami M, Aoki D, Kiguchi K, Iwamori M.

Int J Gynecol Cancer. 2017 Feb;27(2):267-273. doi: 10.1097/IGC.0000000000000693.

PMID:
28114234
48.

Topochemical Analysis of Cell Wall Components by TOF-SIMS.

Aoki D, Fukushima K.

Methods Mol Biol. 2017;1544:249-256. doi: 10.1007/978-1-4939-6722-3_18.

PMID:
28050841
49.

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease.

Wilson MK, Pujade-Lauraine E, Aoki D, Mirza MR, Lorusso D, Oza AM, du Bois A, Vergote I, Reuss A, Bacon M, Friedlander M, Gallardo-Rincon D, Joly F, Chang SJ, Ferrero AM, Edmondson RJ, Wimberger P, Maenpaa J, Gaffney D, Zang R, Okamoto A, Stuart G, Ochiai K; participants of the Fifth Ovarian Cancer Consensus Conference.

Ann Oncol. 2017 Apr 1;28(4):727-732. doi: 10.1093/annonc/mdw663.

PMID:
27993805
50.

Carcinoma of the lower uterine segment diagnosed with Lynch syndrome based on MSH6 germline mutation: A case report.

Adachi M, Banno K, Masuda K, Yanokura M, Iijima M, Takeda T, Kunitomi H, Kobayashi Y, Yamagami W, Hirasawa A, Kameyama K, Sugano K, Aoki D.

J Obstet Gynaecol Res. 2017 Feb;43(2):416-420. doi: 10.1111/jog.13202. Epub 2016 Dec 8.

PMID:
27928858

Supplemental Content

Support Center